1 result(s) displayed (1 - 1 of 1):
GlaxoSmithKline plc is shaking up its strategy. According to the company, it is looking to boost growth and reduce risk by diversifying its global operations through M&A and alliances. With generics crowding the market, it's a popular strategy for drugmakers, including Novartis AG and Johnson & Johnson. According to GSK...
Posted on July 23, 2008 11:28 AM
Movable Type search results powered by Fast Search